Mithridion is a biopharmaceutical company that discovers and develops drugs for central nervous system disorders, with an initial focus on Alzheimer’s disease and schizophrenia.
|
Latest News
April 7, 2009...Mithridion Announces Phase I Clinical Trial Results...more
|
Latest Events
April 7-9, 2009...Mithridion presentation at C21 BioVentures, Napa, CA... meet the CEO...see Events
|
Apologies - website under construction.
|
|